Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation (RDN) technologies. Going into effect on Jan. 1, 2025, the approvals could increase patient access to the new hypertension treatments. Medtronic secured a Transitional Pass-Through (TPT) payment under the Medicare Hospital Outpatient Prospective Payment System for its Symplicity Spyral renal […]
Medtronic
Medtronic studies highlight safety, effectiveness of atherectomy
Medtronic (NYSE:MDT) announced results from two studies evaluating the utility of atherectomy for peripheral endovascular interventions. The Total REALITY study retrospectively compared directional atherectomy (DA) versus balloon predilatation prior to drug-coated balloon (DCB) treatment of long, calcified femoropopliteal lesions. The company also released results from a systematic literature review and meta-analysis, including 305 published clinical […]
The biggest cardiovascular tech stories from TCT 2024
The 2024 edition of the Transcatheter Cardiovascular Therapeutics (TCT) conference once again highlighted significant innovations in cardiovascular care. This year’s event in Washington, D.C., featured company updates on all types of technologies, including heart valves, access and closure devices, drug-eluting implants, intravascular lithotripsy (IVL), renal denervation (RDN) and more. Some of the biggest names in […]
Medtronic adds new chief medical officer from Cleveland Clinic
Medtronic (NYSE:MDT) announced today that it appointed Dr. Matthew Kroh as chief medical officer for Advanced and General Surgical Technologies. The medtech giant said Kroh’s appointment underscores its commitment to advancing surgical innovation and improving patient outcomes. Kroh, a board-certified surgeon, brings fellowship training in advanced laparoscopic and bariatric surgery and surgical endoscopy. He offers […]
Medtronic reports positive long-term renal denervation outcomes
Medtronic (NYSE:MDT) today announced new, long-term study data further supporting its Symplicity Spyral renal denervation (RDN) system. Symplicity Spyral delivers radiofrequency energy to nerves near kidneys in a minimally invasive procedure to treat hypertension. These nerves can become overactive and contribute to high blood pressure. The RDN system holds approval for commercial use in more […]
FDA approves Medtronic’s Affera cardiac mapping and ablation system and Sphere-9 catheter
Medtronic (NYSE:MDT) today said it received FDA approval for its Affera mapping and ablation system with the Sphere-9 catheter. The all-in-one, high-density (HD) mapping, pulsed field ablation (PFA) and radiofrequency (RF) ablation system treats persistent atrial fibrillation (AFib) and offers RF ablation for cavotricuspid isthmus (CTI) dependent atrial flutter. Medtronic also recently received the FDA’s […]
Medtronic wins CE mark for Evolut FX+
Medtronic (NYSE:MDT) announced today that it received CE mark approval for its Evolut FX+ transcatheter aortic valve implantation (TAVI) system. The medtech giant received FDA approval for the same system in March of this year. Both FDA and CE mark approval cover the treatment of symptomatic severe aortic stenosis. It says the latest version of […]
Philips, Medtronic ink stroke advocacy partnership
Philips (NYSE:PHG) and Medtronic (NYSE:MDT) today announced a strategic advocacy partnership centered around stroke care. The two companies joined forces to advocate on raising awareness around potential health and economic benefits for patients, families and societies associated with improving access to timely stroke diagnosis and treatment. Philips and Medtronic Neurovascular also further expanded and strengthened partnerships […]
FDA approves IDE for Medtronic Prevail drug-coated balloon
Medtronic announced today that it received FDA investigational device exemption (IDE) for its Prevail drug-coated balloon (DCB). The medtech giant can now begin a pivotal clinical trial for the coronary paclitaxel DCB for in-stent restenosis (ISR) and de novo small vessel disease. It plans to use data from its Prevail Global Clinical Program to support […]
Stryker’s M&A offensive: Andy Pierce discusses some of the devicemaker’s biggest deals — and a few seen as ‘head-scratchers’
When longtime Stryker CEO John Brown was preparing for the company’s 1979 initial public offering, he set a goal of 20% annual growth every single year. “We did that under John’s leadership for a good 20, 25 years,” Andy Pierce, a 29-year Stryker veteran who’s now president of the MedSurg and Neurotechnology groups, said at […]
FDA says Medtronic can study Affera pulsed field ablation system for treating ventricular tachycardia
Medtronic announced today that the FDA approved an early feasibility study to evaluate its Affera system for treating VT. The company can now evaluate the Affera mapping and ablation system with Sphere-9 catheter for treating sustained ventricular tachycardia (VT). This potentially life-threatening abnormal heart rhythm affects the lower chamber of the heart. Medtronic designed Affera […]
